Search filters

List of works by Joanna Góra-Tybor

2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cells.

scientific article published in January 2000

A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-alpha and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice

scientific article published on January 1994

A multicenter prospective study on efficacy and safety of imatinib generics: A report from Polish Adult Leukemia Group imatinib generics registry

scientific article published on 4 April 2017

Activity of 2-chlorodeoxyadenosine (Cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-Hodgkin's lymphoma

scientific article

Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion: report from the Polish Adult Leukemia Group

scientific article published in January 2009

Antifungal management in adults and children with hematological malignancies or undergoing hematopoietic cell transplantation: recommendations of Polish Society of Hematology and Blood Transfusion, Polish Society of Pediatric Oncology and Hematology

scientific article published in 2020

Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia

scientific article published on June 2003

Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia

scientific article published on 01 January 2005

Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (

scientific article published on 21 March 2006

Cladribine as monotherapy or combined with dexamethasone and idarubicin or mitoxantrone in previously treated patients with low-grade lymphoid malignancies

scientific article published on 01 February 2000

Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia.

scientific article

Cladribine combined with cyclophosphamide and mitoxantrone is an active salvage therapy in advanced non-Hodgkin's lymphoma.

scientific article

Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia

scientific article

Cladribine combined with mitoxantrone in the treatment of blastic phase of chronic myeloid leukemia

scientific article

Cladribine decreases the level of angiogenic factors in patients with chronic lymphocytic leukemia

scientific article published in January 2002

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.

scientific article

Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies.

scientific article

Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia.

scientific article published on 25 November 2014

Clonal proliferation of large granular lymphocytes -- LGL leukemia

scientific article published on 01 January 1995

Coexistence of chronic lymphocytic leukemia and essential thrombocythemia

scientific article

Combination regimen of 2-chlorodeoxyadenosine (cladribine), mitoxantrone and dexamethasone (CMD) in the treatment of refractory and recurrent low grade non-Hodgkin's lymphoma

scientific article published on 01 January 1999

Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis: A Retrospective Analysis of 527 Patients From the Polish Adult Leukemia Group Registry

scientific article published on 09 May 2018

Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study).

scientific article published on 8 March 2010

Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1).

scientific article

Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?

scientific article published on 10 October 2020

Effect of platinum(II) choline complex on murine leukemias L1210 and P388

scientific article published on 01 July 1997

Elevated plasma levels of the angiogenic tetrapeptide acetyl-ser-asp-lys-pro are found in some patients with hematologic malignancies

scientific article published on 01 December 2009

Emerging therapies in chronic myeloid leukemia.

scientific article published on June 2012

Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia

scientific article published on 01 January 2009

Fulminant 2-chlorodeoxyadenosine-related peripheral neuropathy in a patient with paraneoplastic neurological syndrome associated with lymphoma.

scientific article published on April 1996

Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms

scientific article published on 01 September 2020

Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials.

scientific article

Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210

scientific article published on 01 January 1994

Influence of cladribine alone and in combination with cyclophosphamide or cyclophosphamide and mitoxantrone on bone marrow angiogenesis in chronic lymphocytic leukemia

scientific article published on 01 May 2007

Long-term results of the Polish Adult Leukemia Group PALG-CLL2 phase III randomized study comparing cladribine-based combinations in chronic lymphocytic leukemia.

scientific article published on 14 November 2013

Poor prognosis of Hodgkin variant of Richter transformation in chronic lymphocytic leukemia treated with cladribine

scientific article published on 16 April 2012

Preface

Preface to a supplement to Pharmacy World on the 5TH Symposium of the European Society for the Study of Purine & Pyrimidtne Metabolism in Man (ESSPPMM 1995)

Prognostic value of the bone marrow microvessel density in progressive B-cell chronic lymphocytic leukemia

scientific article published on 01 July 2010

Quality of Life and Adherence to Therapy in Patients With Chronic Myeloid Leukemia Treated With Nilotinib as a Second-Line Therapy: A Multicenter Prospective Observational Study.

scientific article published on 10 January 2017

Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment

scientific article

Real-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment.

scientific article published on 5 March 2015

Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs

scientific article published in 2022

Richter syndrome first manifesting as cutaneous B-cell lymphoma clonally distinct from primary B-cell chronic lymphocytic leukaemia

scientific article published in October 2005

Richter's syndrome in the brain first manifested as an ischaemic stroke

scientific article published in June 2004

Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies.

scientific article

Ruksolitynib w terapii chorych na mielofibrozę — pytania i odpowiedzi

scientific article published on 4 March 2019

Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine

scientific article published in February 2004

Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation

scientific article published on 01 February 1998

Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388

scientific article published on 01 January 1993

Targeted drugs in chronic myeloid leukemia.

scientific article published on January 2008

The Influence of 2-Chlorodeoxyadenosine (2-CdA) Alone and in Combination with Cyclophosphamide or Methotrexate on Normal and Leukemic Hematopoiesis ⬇️

scientific article published on 01 January 1994

The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil.

scientific article published in July 2005

The influence of 2- chlorodeoxyadenosine in combination with tumour necrosis factor-alpha or its mutein on murine leukaemias L1210 and P388.

scientific article published on January 1995

The influence of 2-chlorodeoxyadenosine alone and in combination with cyclophosphamide or methotrexate on normal hematopoiesis in mice

scientific article published on 01 January 1993

The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI.

scientific article published on 16 May 2013

The influence of recombinant human tumor necrosis factor (rh-TNF alpha) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukaemic blasts (CFU-L) in cultures in vitro

scientific article published on 01 January 1992

The interaction of 2-chlorodeoxyadenosine (2-CDA) and interferon alpha (IFN-alpha) on normal and myeloid leukemia hematopoiesis in vitro

scientific article published on 01 April 1994

The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease.

scientific article published on November 1998

The susceptibility of Philadelphia chromosome positive cells to FAS-mediated apoptosis is not linked to the tyrosine kinase activity of BCR-ABL.

scientific article

Toxic epidermal necrolysis in a patient with severe aplastic anemia treated with cyclosporin A and G-CSF.

scientific article published in January 2001

Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors

scientific article

Treatment of drug-induced agranulocytosis with colony stimulating factors (G-CSF or GM-CSF)

scientific article published on 01 January 1996

[Apoptosis--programmed cell death]

scientific article published on 01 January 1994

[Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine)]

scientific article published on 01 January 1996

[Clinical pharmacology of hydroxyurea]

scientific article published on 01 January 1995

[Importance of physician-patient relations in therapeutic process of patients with hematological neoplasms]

scientific article published on 01 January 2014

[Reversible pulmonary hypertension as a consequence of dasatinib treatment in a patient with chronic myeloid leukemia and scleroderma].

scientific article

[Tyrosine kinase inhibitors in the therapy of chronic myeloid leukaemia]

scientific article published on 01 January 2006

Paulina is supported by:

About Paulina

Help